medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2013, Number 06

<< Back Next >>

Ginecol Obstet Mex 2013; 81 (06)

Results Following an Action Protocol in Patients with Severe Pelvic Inflammatory Disease

Abehsera-Davó D, Panal-Cusati M, Sánchez-Pastor M, Herrera MM, de Santiago-García FJ

Language: Spanish
References: 19
Page: 304-309
PDF size: 342.26 Kb.


ABSTRACT

Background: Pelvic inflammatory disease is manifested by a broad spectrum of genital tract infections that include: endometritis, salpingitis, tubo-ovarian abscess, and pelvic peritonitis. This disease is associated with evidence of inflammation of the lower genital tract.
Objective: To evaluate the subgroup of patients with a diagnosis of acute pelvic inflammatory disease requiring hospitalization after implementation of the protocol for action in the patient with suspected pelvic inflammatory disease.
Material and methods: Retrospective analysis conducted between January and December 2011 in a cohort of patients diagnosed with severe pelvic inflammatory disease after implementation of a hospital protocol for suspected patients with this condition. Patients who met the diagnostic criteria of Centers for Disease Control and Prevention (CDC) and required hospitalization were considered with severe pelvic inflammatory disease. In all cases the same complementary tests were conducted and the same antibiotic protocol was prescribed.
Results: We included 38 patients and found a statistically significant relationship between the IUD and mixed gramnegative flora etiologic agent (p ‹ 0.05). There was a negative correlation (Pearson correlation coefficient -0.334) between elevated leukocyte at the time of admission and the need for surgery.


REFERENCES

  1. Gradison M. Pelvic inflammatory disease. Am Fam Physician 2012;85:791-796.

  2. Sweet RL. Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management. Curr Infect Dis Rep 2012 Feb 2.

  3. Sexually Transmited diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51:1-78.

  4. Xercavins y col. Enfermedad inflamatoria pélvica. En: Documentos de consenso SEGO 2004. Madrid: Meditex, 2004;105-134.

  5. Hager WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983;61:113-114.

  6. Weström L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980;138:880.

  7. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:1013.

  8. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55:1.

  9. Altunyurt S, Demir N, Posaci C. A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol 2003;107:81-84.

  10. Boardman LA, Peipert JF, Brody JM, Cooper AS, Sung J. Endovaginal sonography for the diagnosis of upper genital tract infection. Obstet Gynecol 1997;90:54.

  11. Lareau SM, Beigi RH. Pelvic inflammatory disease and tuboovarian abscess. Infect Dis Clin North Am. 2008;22:693.

  12. Soper DE, Brockwell NJ, Dalton HP, et al. Observations concerning the microbial etiology of acute salpingitis. Obstet Gynecol Surv 1994;49:689.

  13. Burnett AM, Anderson CP, Zwank MD. Laboratoryconfirmed gonorrhea and/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis. Am J Emerg Med 2011;24.

  14. Haggerty CL, Taylor BD. Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease. Infect Dis Obstet Gynecol. 2011;2011:959816.

  15. Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. Am J Obstet Gynecol 2012;206:476.e1.

  16. Wiesenfeld HC, Hillier SL, Krohn MA, Amortegui AJ, Heine RP, Landers DV, Sweet RL. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002;100:456-463.

  17. Ness RB, Hillier SL, Kip KE, Soper DE, Stamm CA, McGregor JA, Bass DC, Sweet RL, Rice P, Richter HE. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 2004;104:761.

  18. Ness RB, Kip KE, Hillier SL, Soper DE, Stamm CA, Sweet RL, Rice P, Richter HE. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 2005;162:585.

  19. Hsu WC, Lee YH, Chang DY. Tuboovarian abscess caused by Candida in a woman with an intrauterine device. Gynecol Obstet Invest 2007;64:14-16.




2020     |     www.medigraphic.com